SEARCH

SEARCH BY CITATION

References

  • 1
    Meier PJ, Stieger B. Molecular mechanisms in bile formation. News Physiol Sci 2000; 15: 89-93.
  • 2
    Igimi H, Yamamoto F, Lee SP. Gallbladder mucosal function: studies in absorption and secretion in human and in dog gallbladder epithelium. Am J Physiol 1992; 263: G69-G74.
  • 3
    Baiocchi L, LeSage G, Glaser S, Alpini G. Regulation of cholangiocyte bile secretion. J Hepatol 1999; 31: 179-191.
  • 4
    Cho WK, Boyer JL. Vasoactive intestinal polypeptide is a potent regulator of bile secretion from rat cholangiocytes. Gastroenterology 1999; 117: 420-428.
  • 5
    Jansson R, Steen G, Svanvik J. Effects of intravenous vasoactive intestinal peptide (VIP) on gallbladder function in the cat. Gastroenterology 1978; 75: 47-50.
  • 6
    Gunter-Smith PJ, Abdulkadir O, Hammonds-Odie L, Scanlon M, Terrell R. A primary culture of guinea pig gallbladder epithelial cells that is responsive to secretagogues. Am J Physiol Gastrointest Liver Physiol 2000; 279: G866-G874.
  • 7
    Usdin TB, Bonner TI, Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 1994; 135: 2662-2680.
  • 8
    Laburthe M, Breant B, Rouyer-Fessard C. Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross-linking: evidence for two classes of binding sites with different structural and functional properties. Eur J Biochem 1984; 139: 181-187.
  • 9
    Pei L. Identification of a negative glucocorticoid response element in the rat type 1 vasoactive intestinal polypeptide receptor gene. J Biol Chem 1996; 271: 20879-20884.
  • 10
    Madsen B, Georg B, Vissing H, Fahrenkrug J. Retinoic acid down-regulates the expression of the vasoactive intestinal polypeptide receptor type-1 in human breast carcinoma cell lines. Cancer Res 1998; 58: 4845-4850.
  • 11
    Madsen B, Georg B, Madsen MW, Fahrenkrug J. Estradiol down regulates expression of vasoactive intestinal polypeptide receptor type-1 in breast cancer cell lines. Mol Cell Endocrinol 2001; 172: 203-211.
  • 12
    Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999; 284: 1365-1368.
  • 13
    Zavacki AM, Lehmann JM, Seol W, Willson TM, Kliewer SA, Moore DD. Activation of the orphan receptor RIP14 by retinoids. Proc Natl Acad Sci U S A 1997; 94: 7909-7914.
  • 14
    Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science 1999; 284: 1362-1365.
  • 15
    Denson LA, Sturm E, Echevarria W, Zimmerman TL, Makishima M, Mangelsdorf DJ, et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 2001; 121: 140-147.
  • 16
    Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 2001; 276: 28857-28865.
  • 17
    Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000; 6: 517-526.
  • 18
    Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000; 6: 507-515.
  • 19
    Maloney PR, Parks DJ, Haffner CD, Fivush AM, Chandra G, Plunket KD, et al. Identification of a chemical tool for the orphan nuclear receptor FXR. J Med Chem 2000; 43: 2971-2974.
  • 20
    Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest 2003; 112: 1678-1687.
  • 21
    Alpini G, Glaser SS, Ueno Y, Rodgers R, Phinizy JL, Francis H, et al. Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology 1999; 116: 179-186.
  • 22
    Chignard N, Mergey M, Veissiere D, Parc R, Capeau J, Poupon R, et al. Bile acid transport and regulating functions in the human biliary epithelium. HEPATOLOGY 2001; 33: 496-503.
  • 23
    Chignard N, Mergey M, Veissiere D, Poupon R, Capeau J, Parc R, et al. Bile salts potentiate adenylyl cyclase activity and cAMP-regulated secretion in the human gallbladder epithelium. Am J Physiol 2003; 284: G205-G212.
  • 24
    Ballet F, Bouma ME, Wang SR, Amit N, Marais J, Infante R. Isolation, culture and characterization of adult human hepatocytes from surgical liver biopsies. HEPATOLOGY 1984; 4: 849-854.
  • 25
    Kinnman N, Hultcrantz R, Barbu V, Rey C, Wendum D, Poupon R, et al. PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury. Lab Invest 2000; 80: 697-707.
  • 26
    Housset C, Carayon A, Housset B, Legendre C, Hannoun L, Poupon R. Endothelin-1 secretion by human gallbladder epithelial cells in primary culture. Lab Invest 1993; 69: 750-755.
  • 27
    Mergey M, Lemnaouar M, Veissiere D, Perricaudet M, Gruenert DC, Picard J, et al. CFTR gene transfer corrects defective glycoconjugate secretion in human CF epithelial tracheal cells. Am J Physiol 1995; 269: L855-L864.
  • 28
    Dray-Charier N, Paul A, Veissiere D, Mergey M, Scoazec JY, Capeau J, et al. Expression of cystic fibrosis transmembrane conductance regulator in human gallbladder epithelial cells. Lab Invest 1995; 73: 828-836.
  • 29
    Bertrand F, Philippe C, Antoine PJ, Baud L, Groyer A, Capeau J, et al. Insulin activates nuclear factor kappa B in mammalian cells through a Raf-1-mediated pathway. J Biol Chem 1995; 270: 24435-24441.
  • 30
    Xu G, Pan Lx LX, Erickson SK, Forman BM, Shneider BL, Ananthanarayanan M, et al. Removal of the bile acid pool upregulates cholesterol 7alpha- hydroxylase by deactivating FXR in rabbits. J Lipid Res 2002; 43: 45-50.
  • 31
    Dupont C, Broyart JP, Broer Y, Chenut B, Laburthe M, Rosselin G. Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3′,5′-monophosphate in gallbladder epithelial cells of man: comparison with the guinea pig. J Clin Invest 1981; 67: 742-752.
  • 32
    Nyberg B, Einarsson K, Sonnenfeld T. Evidence that vasoactive intestinal peptide induces ductular secretion of bile in humans. Gastroenterology 1989; 96: 920-924.
  • 33
    Couvineau A, Maoret JJ, Rouyer-Fessard C, Carrero I, Laburthe M. The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20. Biochem J 2000; 347(Pt 3): 623-632.
  • 34
    Grober J, Zaghini I, Fujii H, Jones SA, Kliewer SA, Willson TM, et al. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene: involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. J Biol Chem 1999; 274: 29749-29754.
  • 35
    Laffitte BA, Kast HR, Nguyen CM, Zavacki AM, Moore DD, Edwards PA. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J Biol Chem 2000; 275: 10638-10647.
  • 36
    Kast HR, Nguyen CM, Sinal CJ, Jones SA, Laffitte BA, Reue K, et al. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. Mol Endocrinol 2001; 15: 1720-1728.
  • 37
    Urizar NL, Dowhan DH, Moore DD. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J Biol Chem 2000; 275: 39313-39317.
  • 38
    Chiang JY, Kimmel R, Weinberger C, Stroup D. Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J Biol Chem 2000; 275: 10918-10924.
  • 39
    Kassam A, Miao B, Young PR, Mukherjee R. Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding. J Biol Chem 2003; 278: 10028-10032.
  • 40
    Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999; 3: 543-553.
  • 41
    Hwang ST, Urizar NL, Moore DD, Henning SJ. Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor. Gastroenterology 2002; 122: 1483-1492.
  • 42
    Kurumiya Y, Nagino M, Nozawa K, Kamiya J, Uesaka K, Sano T, et al. Biliary bile acid concentration is a simple and reliable indicator for liver function after hepatobiliary resection for biliary cancer. Surgery 2003; 133: 512-520.
  • 43
    Hofmann AF. Bile acids: the good, the bad, and the ugly. News Physiol Sci 1999; 14: 24-29.
  • 44
    Rossi SS, Converse JL, Hofmann AF. High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids. J Lipid Res 1987; 28: 589-595.
  • 45
    Pircher PC, Kitto JL, Petrowski ML, Tangirala RK, Bischoff ED, Schulman IG, et al. Farnesoid X receptor regulates bile acid-amino acid conjugation. J Biol Chem 2003; 278: 27703-27711.
  • 46
    Moschetta A, Bookout AL, Mangelsdorf DJ. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 2004; 10: 1352-1358.